International Journal of Infectious Diseases
Volume 11, Issue 2 , Pages 93-97 , March 2007

Pre-event smallpox vaccination for healthcare workers revisited—the need for a carefully screened multidisciplinary cadre

Received 10 August 2006 ,Revised 2 November 2006 ,Accepted 8 November 2006.

References 

  1. Longini IM, Halloran ME, Nizam A, Yang Y, Shufu X, Burke DS, et al. Containing a large bioterrorist smallpox attack: a computer simulation approach. Int J Infect Dis. 2007;11:98–108
  2. Meltzer MI, Damon I, LeDuc JW, Miller JD. Modeling potential responses to smallpox as a bioterrorist weapon. Emerg Infect Dis. 2001;7:959–969
  3. Kaplan EH, Craft DL, Wein LM. Emergency response to a smallpox attack: the case for mass vaccination. Proc Natl Acad Sci USA. 2002;99:10935–10940
  4. Halloran ME, Longini IM, Nizam A, Yang Y. Containing bioterrorist smallpox. Science. 2002;298:1428–1432
  5. Ferguson NM, Keeling MJ, Edmunds WJ, Gani R, Grenfell BT, Anderson RM, et al. Planning for smallpox outbreaks. Nature. 2003;425:681–685
  6. Bozzette SA, Boer R, Bhatnagar V, Brower JL, Keeler EB, Morton SC, et al. A model for smallpox-vaccination policy. N Engl J Med. 2003;348:416–425
  7. Bicknell WJ. The case for voluntary smallpox vaccination. N Engl J Med. 2002;346:1323–1324
  8. Department of Defense Smallpox Vaccination Program. Smallpox vaccination safety summary. Available at: http://www.smallpox.mil/event/SPSafetySum.asp (accessed 5 June 2006).
  9. Kretzschmar M, Wallinga J, Teunis P, Xing S, Mikolajczyk R. Frequency of adverse events after vaccination with different vaccinia strains. PLoS Med. 2006;3:e272
  10. Department of Defense Smallpox Vaccination Program. Safety panel reports. Available at: http://www.smallpox.mil/event/panelreprt.asp (accessed 6 June 2006).
  11. Poland GA, Grabenstein JD, Neff JM. The US smallpox vaccination program: a review of a large modern era smallpox vaccination implementation program. Vaccine. 2005;23:2078–2081
  12. Halsell JS, Riddle JR, Atwood JE, Gardner P, Shope R, Poland GA, et al. Myopericarditis following smallpox vaccination among vaccinia-naïve US military personnel. JAMA. 2003;289:3283–3289
  13. Eckart RE, Love SS, Atwood JE, Arness MK, Cassimatis DC, Campbell CL, et al. Incidence and follow-up of inflammatory cardiac complications after smallpox vaccination. J Am Coll Cardiol. 2004;44:201–205
  14. Karjalainen J, Heikkila J, Nieminen MS, Jalanko H, Kleemola M, Lapinleimu K, et al. Etiology of mild acute infectious myocarditis. Relation to clinical features. Acta Med Scand. 1983;213:65–73
  15. Helle EP, Koskenvuo K, Heikkila J, Pikkarainen J, Weckstrom P. Myocardial complications of immunizations. Ann Clin Res. 1978;10:280–287
  16. Grabenstein JD, Winkenwerder W. US military smallpox vaccination program experience. JAMA. 2003;289:3278–3282
  17. Casey CG, Iskander JK, Roper MH, Mast EE, Wen XJ, Torok TJ, et al. Adverse events associated with smallpox vaccination in the United States, January–October 2003. JAMA. 2005;294:2734–2743
  18. Centers for Disease Control and Prevention, Office of Enterprise Communication. Smallpox vaccination program status by state. Available at: http://www.cdc.gov/od/oc/media/spvaccin.htm (accessed 9 July 2006).
  19. Sejvar JJ, Labutta RJ, Chapman LE, Grabenstein JD, Iskander J, Lane MJ. Neurologic adverse events associated with smallpox vaccination in the United States. JAMA. 2005;294:2744–2750
  20. Frey SE, Newman FK, Cruz J, Shelton WB, Tennant JM, Polach T, et al. Dose-related effects of smallpox vaccine. N Engl J Med. 2002;346:1275–1280
  21. Rock MT, Yoder SM, Talbot TR, Edwards KM, Crowe JE. Elevated systemic cytokine levels following smallpox immunization. In: Program and abstracts of the 41st IDSA; 9–12 October 2003; San Diego, CA, USA. Abstract 821.
  22. De Palma R, Del Galdo F, Gianfranco A, Chiariello M, Calabro R, Forte L, et al. Patients with acute coronary syndrome show oligoclonal T-cell recruitment within unstable plaque: evidence for local, intracoronary immunologic mechanisms. Circulation. 2006;113:640–646
  23. Libby P. Inflammation in atherosclerosis. Nature. 2002;420:868–874
  24. Engler RJ, Kenner J, Leung DY. Smallpox vaccination: risk considerations for patients with atopic dermatitis. J Allergy Clin Immunol. 2002;110:357–365
  25. Howell MD, Gallo RL, Boguniewicz M, Jones JF, Wong C, Streib JE, et al. Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus. Immunity. 2006;24:341–348
  26. Yih WK, Lieu TA, Rego VH, O’Brien MA, Shay DK, Yokoe DS, et al. Attitudes of healthcare workers in U.S. hospitals regarding smallpox vaccination. BMC Public Health. 2003;3:20–28
  27. Kretzschmar M, van den Hof S, Wallinga J, van Wijngaarden J. Ring vaccination and smallpox control. Emerg Infect Dis. 2004;10:832–841
  28. Woods R, McCarthy T, Barry MA, Mahon B. Diagnosing smallpox: would you know it if you saw it?. Biosecur Bioterror. 2004;2:157–163
  29. Centers for Disease Control and Prevention. Update: multistate outbreak of mumps — United States, January 1–May 2, 2006. MMWR Morb Mortal Wkly Rep. 2006;55:559–563
  30. Qureshi K, Gershon RR, Sherman MF, Staub T, Gebbie E, McCollum M, et al. Health care workers ability and willingness to report to duty during catastrophic disasters. J Urban Health. 2005;82:378–388
  31. Baciu A, Anason AP, Stratton K, Strom B. The smallpox vaccination program—public health in the age of terrorism. Washington, DC, USA: Institute of Medicine, National Academies Press; 2005;

PII: S1201-9712(07)00002-1

doi: 10.1016/j.ijid.2006.11.005

International Journal of Infectious Diseases
Volume 11, Issue 2 , Pages 93-97 , March 2007

Article Tools